The U.S. Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for ...

The Muscular Dystrophy Association (MDA) today launched the nation’s largest St. Patrick’s Day fundraising campaign, MDA Shamrocks, as part of its celebration of 75 years of progress and impact in ...

The National Pharmaceutical Pricing Authority directs pharma firms to revise the MRP of medicines following customs duty ...

Battling inclement weather the entire climb, 18-year-old Jaden Lim took on the country’s highest mountain to raise funds for ...

In the face of looming revenue decline from blood cancer medication Revlimid, Indian pharma companies Natco Pharma and Dr.

Emma Larson's life was saved by a miracle drug. Those stories could cease to exist if NIH funding cuts proposed by DOGE go into effect.

New Mexico Educational Retirement Board decreased its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.8% during the fourth quarter, according to the company in its most recent ...

Biogen Inc. has agreed to pay as much as $550 million to develop and sell a drug to treat a genetic seizure disorder, the latest effort by the biotech company to fill holes in its pipeline.Biogen will ...

Researchers have developed a regenerative medicine method that successfully grafts myoblasts onto healthy muscle, boosting ...

In COPD, muscular atrophy is a significant risk factor for death and may prolong patients’ hospital length of stay.

In an office memorandum dated February 17, the nodal agency for price regulation has also directed these companies to issue a revised price list indicating the changes in rates for the benefit of ...

A new discovery offers hope for Huntington’s disease. This discovery provides hope that a DNA repair process may help slow or ...